Catalyst Event
3SBio Inc (1530) · Earnings Release
From Akros SCHK HK-Global Brain-Computer Interface Index (ASHGBCI)
8/26/2026, 12:00:00 AM
First half 2026 earnings results are expected to be released around August 26, 2026, expected. High importance is estimated due to the significant impact of previous earnings growth on stock volatility.
Korean Translation
2026년 상반기 실적 발표가 2026년 8월 26일경 진행될 것으로 예상됨. 이전 실적의 높은 성장세가 주가 변동성에 미치는 영향을 고려하여 높은 중요도로 예상함.
Related Recent Events
Cochlear Ltd (COH) · Earnings Release
Cochlear's full-year financial results for fiscal year 2026 are scheduled to be announced on August 18, 2026. Medium importance is estimated as annual earnings reports typically result in price movements exceeding 5%, scheduled.
8/18/2026, 12:00:00 AM
3SBio Inc (1530) · Other
The ex-dividend date for the final cash dividend of HKD 0.25 per share for the fiscal year 2025 is July 21, 2026, scheduled.
7/21/2026, 12:00:00 AM
Sino Biopharmaceutical Ltd (1177) · Other
The ex-dividend date for the proposed final dividend of HKD 0.05 per share is 2026-06-24, which is estimated to have a price impact of ≥1% scheduled.
6/24/2026, 12:00:00 AM
Innovent Biologics Inc (1801) · Other
Innovent will present obesity pipeline data at the ADA Scientific Sessions on June 5-8, 2026; this low-impact event is scheduled
6/5/2026, 12:00:00 AM
Medtronic PLC (MDT) · Earnings Release
Medtronic to report Q4 and full fiscal year 2026 financial results, scheduled.
6/3/2026, 12:00:00 AM
Giant Biogene Holding Co Ltd (2367) · Other
Ex-dividend date of 2026-06-01 for final and special dividends, scheduled. (Estimated Low impact as dividend is standard).
6/1/2026, 12:00:00 AM